Illustration of a clinic building (not a photo of Dana-Farber Cancer Institute, Inc.)
Illustration

Robert I. Haddad, MD

Medical Oncology in Boston, MA

  • Enrolled in Medicare
  • Accepts Medicare assignment
  • Offers telehealth
  • 31 years since graduation
  • Public record — not managed by the clinician

About Dr. Robert Haddad

Dr. Robert Haddad is a physician specializing in medical oncology practicing in Boston, MA. Affiliated with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute and 1 more. Treated 153 Medicare patients in 2024.

Provider details

SpecialtyMedical OncologyOther medical oncology doctors in Boston
Also practicesInternal Medicine
CredentialsMD
GenderMale
NPI number1942259098National Provider Identifier (CMS NPPES), issued May 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians
TelehealthOffers telehealth servicesCMS Doctors and Clinicians

Dr. Robert Haddad's specialties and state licenses

  • Medical Oncology Primary
    License: MA 209545

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Where Dr. Robert Haddad practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Hospital affiliations of Dr. Robert Haddad

  • Beth Israel Deaconess Medical CenterHospital · Boston, MA
  • Brigham and Women's HospitalHospital · Boston, MA
  • Dana-Farber Cancer InstituteHospital · Boston, MA
  • Mass General Brigham Home Care, IncHome health agency · Newton, MA

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Robert Haddad's Medicare quality score (MIPS 2024)

84.1/100final MIPS score
65quality
100promoting interoperability
40improvement activities
69.1cost

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.

Dr. Robert Haddad's Medicare patients and services (2024)

153Medicare patients
383services billed
72average patient age
18%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more128$69.17
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more127$102.05
Diagnostic exam of voice box using a flexible endoscope97$74.65
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more21$190.15

Common conditions among these patients

  • High cholesterol69%
  • High blood pressure64%
  • Arthritis34%
  • Ischemic heart disease29%
  • Cancer22%
  • Mood disorders20%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Payments from drug and device companies to Dr. Robert Haddad (2025)

$111,352.45 in 81 general payments reported in 2025, plus $1,720.29 in research payments.

TypePaymentsAmount
Consulting fees16$52,094.43
Travel and lodging33$49,621.28
Compensation for services other than consulting1$7,680
Food and beverage31$1,956.74

Paying companies: Merck Sharp & Dohme LLC ($56,080.60), Exelixis Inc. ($10,119.64), GlaxoSmithKline, LLC. ($8,236.75), Genmab U.S., Inc. ($8,121.51), Hikma Pharmaceuticals USA ($7,732.65), Boehringer Ingelheim International GmbH ($4,800).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Also at Dana-Farber Cancer Institute, Inc.

Questions about Dr. Robert Haddad

What kind of clinician is Dr. Robert Haddad?

Dr. Robert Haddad is listed as a physician specializing in medical oncology, also practicing internal medicine.

Where does Dr. Robert Haddad practice?

Dana-Farber Cancer Institute, Inc. at 450 Brookline Ave, Boston, MA 02215.

What is the NPI number of Dr. Robert Haddad?

The National Provider Identifier is 1942259098.

Does Dr. Robert Haddad accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Robert Haddad affiliated with?

Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Mass General Brigham Home Care, Inc.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2007-09-05
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

Need an appointment?

Visit the clinic page to see how to book.

Clinic page
0 clinics selected Compare